Attractive Sectors 1. 2 10% 2.. 2.8% 3.5% (2014 ) 2.3% 2.5% 2.5% 4.1% 25.4% 4.9% 1 : 32.6% 3 : 9.2% 2 : 10.3% * "The World Pharmaceutical Markets Fact Book 2014" espicom a part of BMI Research '', 65., ''( ). 2013 6 ' ( 再興 ) ' '' 2014 7 ' '. ' ' 2014 5. 1.9% 2.8% 3.3% 1.9% 4.4% 5.5% 23.9% 3 : 7.9% 1 : 39.3% 2 : 9.1%.,,. ICT(). * "Worldwide Medical Market Forecasts to 2019" espicom a part of BMI Research 1
(%) 50.0 40.0 38.8 30.0 32.3 26.3 24.7 20.0 22.2 10.0 2000 2010 2020 2030 2040 2050 ( ) *: United Nation World Population Prospects, the 2015 Revision (1:) 50.0 (2: ) 50 40.0 36.0 37.4 38.5 39.2 40.0 40 30.0 20.0 28.2 29.2 30.1 30.7 31.4 30 20 10.0 10 0.0 2009 2010 2011 2012 2013 ( ) 0 1 2 *: '2013' 2
ライフサイエンス 2. 1 ( 創藥 ) 1 ( ) 2010. 2,.. 2 Unmet Medical Needs ( )( ),. 2014 6.,. (*).. a.. b.. 3 (Orphan Drug), 1993. (NIBIO).,, GSK,,, 20. Unmet Medical Needs,,, COPD(),,,. 2009 ' (PDSC)'.,,,,, 20,. 5 2005 PMDA( ).. 6 2002.. 7.. 3
2 1 2014 11 25 ',, ' ( )..,.. (*) PMDA( ). 2 ( 新法 ) 1 ' ()'..,.. 3 2014 (). 2015 1 1 ' ' 306. 2015 150, 1,820. 4
3. 1. 1 2 (,, ) () 2013 103.2% 2 6,757, 1 3,008, 48.6%. 2014. () 30,000 24,000 18,000 12,000 6,000 0 1 兆 1,010 1 兆 749 1 兆 2,600 1 兆 554 1 兆 3,276 1 兆 583 1 兆 4,051 1 兆 1,883 1 兆 3,749 1 兆 3,008 2009 2010 2011 2012 2013 ( ) - (%) *: 100.0 80.0 60.0 40.0 20.0 0.0,, (MRI). a. ''. 2014 105.4% 245. 2018 276. ( ),, MC (Karl Storz ),. b.. Intuitive Surgical, Inc. ' (da Vinci)', 200.. c.(mri) 100 MRI 1. X CT MRI 2014 531., 2018 547. ( ),, GE,,. 5
2 2013 101.9% 9 8,416. 3 773.,. 2009 24.2%, 2013 31.3% 4 7.1%. () (%) 100,000 40 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 7.2% 7.7% 8.7% 35.6% 30.9% 30.9% 31.6% 26.5% 32.0% 25.2% 29.9% 34.0% 2 0 1 2 2 0 1 3 2 0 1 4 ( ) 80,000 60,000 40,000 20,000 *: ' ( )' ' '. 0 6 兆 6,568 2 兆 1,264 6 兆 6,346 2 兆 3,165 6 兆 8,489 2 兆 5,312 6 兆 8,390 2 兆 8,174 6 兆 7,643 3 兆 773 2009 2010 2011 2012 2013 ( ) - 5 2014 34%, 30.9%, 26.5%, 8.7%.,. 36 32 28 24 20 * *: 2015 ~ 2016 10 (11) 1 28 52 2 24 48 3 21 46 4 20 42 5 MSD 17 30 5 () 13 30 5 9 30 8 15 28 9 10 8 17 23 22 10 6 22 *: ''(2016 3 4 ) 10 9 ' '. 6
,. a. 2015 6 2017 70% 2018 2020 80%.,,,,,,,., JCR,,,, (Meiji Seika Pharma),,, ( 陽進堂 ),,,,,. () 16,000 14,000 12,000 10,000 9,315 1,165 1 1,130 1 2,180 1 4,715 1 3,430 8,000 6,000 4,000 2,000 0 2012 2013 2014 2015 () 2016 () *: 2015 2017 () ( ) b.., Epoetin alfa Filgrastim 2014 110. ( ) 2009 3 ' ' 2009.. 7
3 2014 11 ( ). () 30,000 25,000 20,000 15,000 10,000 5,000 0 () 91 2012 () 954 2020 () 1 309 2030 () 2 5,458 2050 ( ) () *:, ips. ( ips),.,.,,., FIRM ( ) 2011 185 (2016 1 ). FIRM T/F(RMIT),,,.,, ( ), (biological safety cabinet). (Flow Cytometer) DNA. ( )., (( ) Gibco 100% )(Lonza).,,. US/EU (, ) ( 2014 11 ) 6 3 US/EU (2014 11 ) / *: (2013 ) JETRO 8
2 () GDP. ( 医科 ) 3 1. '', ' ', ' ', (, ) 2013 4 2020 10.,. a. (2015 5 ) b. (2015 9 ) c. ICT 90% (2020 ) (2018 ) 017 7, 2018 d. (, ) () e. *: '2016 1', ' ' ICT,. 1 ICT ''. ' ' ( 移乗 ), ' 5' 2014., '' '' 2015 167 2035 4,043. ' ', CYBERDINE,,. 2,., DNA, DNA., 2014 7,108 2018 9,143. ( ),,,. 3,..,,,,. 2014 270 2018 288, 2014 500 2018 560. ( ),,. 9
4 ( ), 2016 4 ''... 5 2025. ICT IT. NEC 'HumanBridge EHR ', NEC 'ID-Link'. 'Infomity'.,,,, JETRO. JETRO. JETRO. (JETRO) https://www.jetro.go.jp/kr/invest/ Copyright (C) 2016 JETRO. All rights reserved. 10